Cargando…
Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy
INTRODUCTION: A litany of recent evidence supports the morbidity of intra-natal iron-deficiency anemia and its prodrome, iron deficiency. Oral iron administered during second and third trimesters does not get to the developing fetus if the mother is iron deficient. This is especially concerning as t...
Autores principales: | Gerb, Jesse, Strauss, William, Derman, Richard, Short, Vanessa, Mendelson, Ben, Bahrain, Huzefa, Auerbach, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170347/ https://www.ncbi.nlm.nih.gov/pubmed/34104372 http://dx.doi.org/10.1177/20406207211018042 |
Ejemplares similares
-
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
por: Vadhan-Raj, Saroj, et al.
Publicado: (2017) -
Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
por: Adkinson, N. Franklin, et al.
Publicado: (2018) -
Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
por: Macdougall, Iain C., et al.
Publicado: (2019) -
Financial burden associated with discordance to intravenous iron therapies in US patients with iron deficiency anemia
por: Polson, Michael K, et al.
Publicado: (2023) -
Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia
previously unresponsive to or unable to tolerate oral iron
por: Vadhan-Raj, Saroj, et al.
Publicado: (2014)